Donato Leslie E's Form 4 filing
Keenova Therapeutics plc (MNKTQ) · filed Jun 4, 2026
- Accession no.
- 0001104659-26-070521
- Filed
- Jun 4, 2026
- Trade date
- Jun 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001104659-26-084773 (Jul 17, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Donato Leslie ECIK 0001784795 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Ordinary Shares | MOption exerciseAcquired | +4,882 | – | – | 4,882 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Ordinary Shares | MOption exerciseDisposed | −4,882 | $0.00 | $0 | 3,984 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.